| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥24.1B | ¥26.8B | -10.0% |
| Operating Income | ¥2.3B | ¥-2.0B | +213.3% |
| Ordinary Income | ¥2.4B | ¥-2.0B | +219.7% |
| Net Income | ¥1.6B | ¥-2.2B | +172.8% |
| ROE | 2.7% | -3.7% | - |
FY2026 Q2 results show Revenue of 24.1B yen (YoY -10.0%), Operating Income of 2.3B yen (prior period -2.0B yen loss, returning to profitability with +213.3% improvement), Ordinary Income of 2.4B yen (prior period -2.0B yen loss, +219.7%), and Net Income of 1.6B yen (prior period -2.2B yen loss, +172.8%). The company achieved a significant turnaround from losses to profitability despite top-line contraction. Operating margin improved to 9.5% from prior period losses, with gross profit margin at 47.4% and SG&A ratio compressed to 37.8%. Cash position remains robust at 50.2B yen, representing 75.3% of total assets. Operating cash flow of 1.3B yen (YoY +36.8%) and free cash flow of 2.0B yen demonstrate continued cash generation capability. The equity ratio of 90.8% and current ratio of 10.6x indicate strong financial stability, though revenue decline and inventory management warrant monitoring.
Revenue declined 10.0% YoY from 26.8B yen to 24.1B yen, driven by reductions across multiple business segments. Despite the top-line decline, gross profit margin remained healthy at 47.4%, with cost of sales of 12.7B yen representing effective cost management. The most significant driver of profitability improvement was SG&A expense reduction to 9.1B yen (37.8% of revenue), down from prior period levels that had contributed to operating losses. This cost restructuring enabled the company to swing from an operating loss of 2.0B yen to an operating profit of 2.3B yen, representing a 9.5% operating margin. Segment notes indicate that corporate headquarters costs of 196M yen are allocated to segment profit calculations, with inter-segment eliminations of 36.9M yen and non-consolidated subsidiary management fees of 0.9M yen affecting the consolidated figures. Non-operating income contributed positively, with ordinary income reaching 2.4B yen, only marginally higher than operating income, suggesting limited non-operating factors. Special items impacted the income statement, with special income of 96M yen and special losses of 140M yen, resulting in profit before tax of 1.9B yen. The tax burden coefficient of 82.7% brought net income to 1.6B yen. The gap between ordinary income of 2.4B yen and net income of 1.6B yen represents approximately 33%, primarily attributable to special losses and tax effects rather than extraordinary operating factors. This represents a revenue down, profit up pattern, where operational efficiency improvements and cost discipline offset declining sales volumes to achieve profitability restoration.
The company operates five business segments with varying scale and profitability profiles. Functional Food Retailing is the largest segment by revenue at 932.7M yen with operating income of 217.1M yen, generating an operating margin of 23.3%, establishing it as the core business with the highest absolute profit contribution. Functional Cosmetic Retailing generated revenue of 726.1M yen with operating income of 82.9M yen, representing an 11.4% margin. Healthcare Support Service recorded revenue of 460.3M yen with operating income of 74.9M yen, achieving a 16.3% margin. Functional Material Development contributed revenue of 180.0M yen with operating income of 18.9M yen at a 10.5% margin. Clinical Evidence Service is the smallest segment at 131.4M yen revenue with operating income of 10.8M yen, representing an 8.2% margin. Material margin differences across segments are significant, with Functional Food Retailing demonstrating the strongest profitability at 23.3% compared to Clinical Evidence Service at 8.2%, a spread of 15.1 percentage points. The Functional Food Retailing segment's combination of scale and margin performance positions it as the primary earnings driver, accounting for approximately 54% of total segment operating income before corporate cost allocations.
[Profitability] ROE of 2.7% reflects the early stage of profit recovery from prior period losses, with the three-factor DuPont analysis showing net profit margin of 6.7%, total asset turnover of 0.362, and financial leverage of 1.10. Operating margin of 9.5% represents a significant improvement from prior period operating losses, though positioned near the lower end of typical healthy ranges. Gross profit margin of 47.4% indicates reasonable pricing power and product economics. [Cash Quality] Cash and equivalents of 50.2B yen provide short-term debt coverage of 8.2x against current liabilities of 6.1B yen, demonstrating exceptional liquidity. However, cash conversion ratio of 0.57 falls below optimal levels, with operating CF to net income ratio of 0.83 indicating some earnings quality considerations. [Investment Efficiency] Asset turnover of 0.362 reflects moderate asset utilization efficiency, influenced by the high proportion of cash holdings. Days inventory outstanding of 116 days and receivables turnover of 87 days (calculated from working capital movements) suggest room for working capital optimization. CapEx to depreciation ratio of 5.61 indicates investment above maintenance levels despite modest absolute amounts of 0.3B yen. [Financial Health] Equity ratio of 90.8% represents a highly conservative capital structure with minimal financial risk. Current ratio of 10.6x and quick ratio of 10.0x provide substantial liquidity cushions. Debt-to-equity ratio of 0.10 and financial leverage of 1.10 confirm minimal reliance on borrowed capital. The balance sheet shows no reported long-term debt, with total liabilities of only 6.1B yen against equity of 60.6B yen.
Operating cash flow of 1.3B yen represents 0.83x of net income of 1.6B yen, indicating reasonable cash backing of reported earnings though slightly below optimal unity ratio. The operating cash generation improved 36.8% YoY, demonstrating strengthening operational cash dynamics. Investing cash flow of 0.7B yen reflects capital deployment activities, with CapEx of 0.3B yen representing ongoing facility and capability investments. Depreciation and amortization of 0.1B yen compares to CapEx of 0.3B yen, yielding a CapEx to D&A ratio of 5.6x, suggesting growth-oriented capital allocation rather than pure maintenance spending. Financing cash flow of negative 1.4B yen indicates net cash returns to stakeholders or debt repayments. Free cash flow of 2.0B yen (operating CF plus investing CF) demonstrates strong surplus cash generation after all investment needs, providing capacity for shareholder distributions and strategic flexibility. The FCF coverage of expected annual dividends of 261M yen (10 yen per share times 26.2M shares) stands at 7.7x, indicating substantial dividend sustainability from current cash generation. Working capital movements show accounts receivable increased by 0.6B yen (up 26.9% YoY) while accounts payable decreased by 0.88B yen (down 46.1% YoY), representing working capital absorption that constrained operating cash flow relative to profit levels. The substantial cash position of 50.2B yen relative to enterprise scale provides significant strategic and operational flexibility.
Ordinary income of 2.4B yen versus operating income of 2.3B yen shows minimal non-operating net contribution of approximately 0.1B yen, suggesting core business operations drive substantially all earnings. The non-operating income components are not material relative to the operating profit base, representing less than 5% of operating income. Special items impacted earnings quality assessment, with special income of 96M yen and special losses of 140M yen, resulting in a net special loss of 44M yen that reduced profit before tax to 1.9B yen from ordinary income of 2.4B yen. These non-recurring items represent approximately 1.8% of revenue, indicating limited impact on underlying earnings power. The primary earnings quality consideration stems from the operating cash flow to net income ratio of 0.83, below the ideal 1.0 threshold, combined with a cash conversion ratio of 0.57 that signals working capital consumption. This divergence is explained by accounts receivable expansion of 0.6B yen and accounts payable reduction of 0.88B yen, absorbing approximately 1.5B yen of cash that would otherwise have been generated. Inventory levels of 3.4B yen with days inventory outstanding of 116 days and work-in-process ratio of 56.4% suggest potential inventory management challenges that could affect future cash realization. The absence of reported impairment losses in any reporting segment supports asset quality, though the high inventory turnover days warrant monitoring for potential obsolescence risk. Overall earnings quality is adequate given operating cash flow remains positive and the company returned to profitability, though working capital efficiency improvements would strengthen cash earnings conversion.
Progress against full-year guidance shows Revenue at 24.1B yen representing 60.3% of the 40.0B yen full-year forecast, Operating Income at 2.3B yen representing 460% of the 0.5B yen full-year forecast, and Ordinary Income at 2.4B yen representing 400% of the 0.6B yen full-year forecast. At Q2, the standard progress rate expectation is 50%, indicating Revenue is tracking 10.3 percentage points ahead of pro-rata expectations. However, Operating Income and Ordinary Income progress rates significantly exceed full-year guidance, suggesting either conservative full-year planning or anticipated second-half profit deterioration. The company's full-year guidance implies second-half operating losses of 1.8B yen compared to first-half profit of 2.3B yen, representing a dramatic sequential decline. This guidance structure indicates management expects substantial headwinds in H2, potentially from seasonal factors, planned investments, or market conditions. Net income guidance of 0.3B yen for the full year implies expected second-half net loss of 1.3B yen against first-half profit of 1.6B yen. EPS forecast of 1.15 yen for the full year compares to H1 actual of 6.19 yen, reinforcing the significant expected H2 deterioration. The full-year revenue guidance of 40.0B yen represents a 17.5% decline from the prior year, indicating ongoing top-line pressures. Without disclosed order backlog data, forward revenue visibility relies on management's market outlook and pipeline assessments embedded in guidance assumptions.
Annual dividend forecast of 10.00 yen per share comprises an expected year-end dividend of 5.00 yen with no interim dividend for Q2. Based on the current net income of 1.6B yen for the first half and shares outstanding of 26.2M, the implied payout ratio is 81.2% if calculated against H1 earnings, indicating a high distribution rate. However, against full-year forecast net income of approximately 0.3B yen (based on EPS guidance of 1.15 yen), the 10.00 yen annual dividend would imply a total payout of approximately 261M yen, representing an 87% payout ratio against forecast full-year earnings. This elevated payout ratio relative to expected full-year profits suggests management confidence in underlying business stability and cash generation despite anticipated H2 earnings decline. The dividend policy appears prioritized toward shareholder returns, supported by the substantial cash position of 50.2B yen and free cash flow generation of 2.0B yen that provides 7.7x coverage of expected annual dividends. No share buyback programs are disclosed in the current period data. Total shareholder returns are therefore limited to dividends, with the total return ratio approximating the 87% payout ratio based on full-year forecasts. Prior year comparisons are limited due to prior period losses, making historical dividend sustainability assessment difficult, though current cash reserves and debt-free balance sheet support distribution capacity.
Revenue decline risk remains elevated, with Q2 showing 10.0% YoY contraction and full-year guidance indicating further 17.5% decline, suggesting potential market share loss, pricing pressure, or end-market demand weakness across business segments. The deterioration from prior periods indicates this is an ongoing trend rather than temporary disruption, warranting close monitoring of customer retention, competitive positioning, and market dynamics. Quantitatively, continued double-digit revenue declines would pressure profitability even with cost management, particularly as fixed cost leverage diminishes.
Inventory management and working capital efficiency present material operational risks, with days inventory outstanding of 116 days, work-in-process inventory comprising 56.4% of total inventory, and cash conversion ratio of 0.57 indicating suboptimal working capital deployment. The simultaneous expansion of accounts receivable by 0.6B yen (up 26.9%) and contraction of accounts payable by 0.88B yen (down 46.1%) consumed approximately 1.5B yen of operating cash flow. If inventory turnover deteriorates further or receivables collection extends, cash generation could be materially impaired, potentially requiring inventory write-downs or collection actions.
Profitability sustainability risk centers on the H2 earnings outlook embedded in guidance, which implies operating losses of 1.8B yen in the second half versus H1 profit of 2.3B yen. This 4.1B yen sequential swing represents substantial execution risk and could stem from seasonal patterns, planned strategic investments, or competitive pressures. The high dividend payout ratio of 87% against full-year forecast earnings leaves limited margin for forecast misses, potentially requiring dividend reductions or cash reserve draws if H2 performance deteriorates beyond guidance assumptions.
[Industry Position] (Reference - Proprietary Analysis)
The company's profitability metrics show mixed positioning within the IT and Telecom industry peer group. ROE of 2.7% falls below the industry median of 5.6% (IQR: 0.7%-6.2%), reflecting the early stage of profit recovery from prior period losses. Operating margin of 9.5% positions below the industry median of 14.0% (IQR: 3.8%-18.5%), though within the normal range, while net profit margin of 6.7% also trails the industry median of 9.2% (IQR: 1.1%-14.0%). These profitability gaps indicate room for margin improvement to reach peer performance levels.
Financial health metrics demonstrate exceptional positioning. Equity ratio of 90.8% substantially exceeds the industry median of 60.2% (IQR: 50.8%-88.4%), ranking among the most conservative capital structures in the peer group. Current ratio of 10.6x significantly surpasses the industry median of 7.7x (IQR: 3.2x-8.1x), reflecting superior short-term liquidity. Financial leverage of 1.10 is well below the industry median of 1.55 (IQR: 1.13-1.76), confirming minimal financial risk relative to peers.
Efficiency and growth metrics reveal challenges. Asset turnover of 0.362 slightly exceeds the industry median of 0.35 (IQR: 0.29-0.37), indicating comparable asset utilization efficiency within a generally asset-light industry structure. However, revenue growth of negative 10.0% sharply underperforms the industry median growth of positive 21.0% (IQR: 15.5%-26.8%), placing the company in the bottom quartile for top-line momentum. Cash conversion ratio of 0.57 falls well below the industry median of 1.22 (IQR: 0.86-1.75), highlighting working capital management as a relative weakness. The Rule of 40 metric combining growth and profitability yields negative 0.5% (growth -10.0% plus operating margin 9.5%), substantially below the industry median of 31% (IQR: 20%-51%), indicating underperformance on this composite growth-profitability measure.
Operating working capital turnover of approximately 110 days aligns reasonably with the industry median of 115 days (IQR: 66-177 days), though receivables and payables management show divergence from typical patterns. CapEx to depreciation ratio of 5.6x significantly exceeds the industry median of 0.34x (IQR: 0.24x-1.70x), suggesting more aggressive capital investment relative to depreciation compared to peers, though absolute amounts remain modest.
Overall, the company exhibits fortress-like financial stability with exceptional liquidity and minimal leverage, but faces profitability and growth challenges relative to industry peers. The priority areas for improvement to reach median peer performance are revenue growth restoration, operating margin expansion toward the 14% industry median, and working capital efficiency enhancement to improve cash conversion.
(Industry: IT and Telecom, N=7 companies, Comparison: FY2025-Q2 medians, Source: Proprietary analysis)
The return to profitability with 2.3B yen operating income after prior period losses demonstrates successful cost restructuring and operational discipline, though achieved against a backdrop of 10.0% revenue decline. This profitability recovery is primarily driven by SG&A expense reduction to 37.8% of revenue and maintained gross margins of 47.4%, indicating management's ability to rightsize the cost structure. However, sustainability depends on stabilizing revenue trends, as continued top-line erosion would challenge fixed cost absorption. The full-year guidance implying significant second-half profit deterioration from 2.3B yen H1 operating profit to guidance-implied negative 1.8B yen H2 operating loss suggests material seasonal or strategic factors that require monitoring. This guidance conservatism may indicate management caution or known headwinds, creating either downside risk if realized or potential upside if mitigated.
Working capital management emerges as a critical operational focus area, with cash conversion ratio of 0.57 and inventory days of 116 indicating suboptimal efficiency. The simultaneous expansion of receivables by 0.6B yen and contraction of payables by 0.88B yen absorbed 1.5B yen of operating cash that otherwise would have strengthened financial flexibility. Work-in-process inventory comprising 56.4% of total inventory at 3.4B yen suggests potential production cycle inefficiencies or demand-supply mismatches. Improvements in these working capital metrics would directly enhance cash generation and provide management with greater strategic flexibility. The operating cash flow to net income ratio of 0.83, while adequate, indicates room for improvement through working capital optimization.
The fortress balance sheet with 50.2B yen cash (75.3% of assets), 90.8% equity ratio, and zero debt provides exceptional financial flexibility and downside protection during the business transition. This conservative capital structure supports the 87% dividend payout ratio against full-year forecast earnings, with free cash flow of 2.0B yen providing 7.7x coverage of expected 261M yen annual dividends. The substantial cash reserves create optionality for strategic investments, business development, or enhanced shareholder returns while maintaining stability through revenue challenges. However, the low asset turnover of 0.362 and minimal financial leverage of 1.10 suggest potential opportunities to deploy capital more productively to drive growth or returns, particularly given revenue headwinds limiting organic growth prospects.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.